Pricing Studies

• World Health Organization Page on Pricing for drugs on its Essential Drugs List.
• Medecins Sans Frontiers. Untangling the Web of Price Reductions: a Pricing Guide for the Purchase of ARVs for Developing Countries. (9th ed. - July, 2006) Also available online, the eighth edition (June 2005), seventh edition (February 2005), sixth edition (April 2004), fifth edition (December 2003), fourth edition (April 2003), second edition (June 2002), and first edition (October 2001).
• Pan American Health Organization Page on Antiretroviral Prices - includes country-by-country data, as well as a number of reports.

• May 30, 2006. Health Action International. Price, availability and affordability. An international comparison of chronic disease medicines.
• April, 2006. John E. Calfee, Mario Villarreal and Elizabeth DuPré. Working Paper 06-07, American Enterprise Institute - Brookings Join Center for Regulatory Studies. An Exploratory Analysis of Pharmaceutical Price Disparities and Their Implications Among Six Developed Nations.
  • Full Text
  • Abstract
• January, 2005. World Health Organization. Sources and Prices of Active Pharmaceutical Ingredients.
• May, 2004. Esssential Drugs Monitor 33 Special Pricing Supplement
• May 11, 2004. Carol C. Adelman, Jeremiah Norris, and S. Jean Weicher for the Hudson Institute. Myths and Realities on Prices of AIDS Drugs. Also, see the critical response from Medecins Sans Frontieres.
• 2003, June 23. UNICEF, UNAIDS, the World Health Organization and Medicins Sans Frontiers. Sources and prices of selected drugs and diagnostics for people living with HIV/AIDS,
• 2002, May. UNICEF, UNAIDS, the World Health Organization and Medicins Sans Frontiers. Sources and prices of selected drugs and diagnostics for people living with HIV/AIDS.
• 2001, October 5. Carmen Perez-Casas, Cécile Macé, Daniel Berman, and Julia Double for MSF. Accessing ARVs: Untangling the Web of Price Reductions for Developing Countries.
• 2001, July. Australian Productivity Commission. International Pharmaceutical Price Differences.
• 2001, July. Office of Rep. Gutknecht. Outrageously High Drug Prices.
• 2001, July 10. Families USA. Off the Charts: Pay, Profits and Spending in Drug Companies. Here is the pres release that accompanies the report.
• 2001, June 12. Families USA. Enough to Make You Sick: Prescription Drug Prices for the Elderly. Here is the press release that accompanies the report.
• 2001, May. UNICEF, UNAIDS, the World Health Organization and Medicins Sans Frontiers. Sources and prices of selected drugs and diagnostics for people living with HIV/AIDS.
• May 2001. Alliance for Retired Americans. The Profit In Pills.
• December, 2000. The Wellcome Trust, the Institute for Global Health, and the Commission on Macroeconomics and Health. Intellectual Property Rights and Global Health: Challenges for Access and R&D. Focuses on differential pricing, as well as R&D for neglected diseases.
• 2000, October. Joint projct of UNAIDS, UNICEF, the World Health Organization's Essential and Drugs Medicines Policy, and Medicins sans Frontieres. Selected drugs used in the care of people living with HIV: sources and prices.
• 2000, August 8. Joseph DiMasi, Tufts Center for the Study of Drug Development. Price Trends for Prescription Pharmaceuticals: 1995-1999. (A background report prepared for the Department of health and Human Services' Conference on Pharmaceutical Pricing Practices, Utilization and Costs.)
• 2000, July 11, 2000, Panos Institute, Beyond Our Means? The Cost of Treating HIV/AIDS in the Developing World
• 2000, July 7, 2000, MSF, Carmen Pérez-Casas et al., HIV/AIDS medicines pricing report. Setting objectives: is there a political will?
• 2000, June 24, Fred J. Hellinger and John A. Fleishman, in Journal of Acquired Immune Deficiency Syndromes, Estimating the National Cost of Treating People With HIV Disease: Patient, Payer, and Provider Data
• 2000, April/May, Dr. K Balasubramaniam and Kiran Sagoo, HAINEWS NUMBER 112, Patents and Prices
• 2000 April. Department of Health and Human Services. Issues in Prescription Drug Coverage, Pricing, Utilization and Spending: What We Know and Need to Know (Appendix A).
• 2000, February 26. R.O. Laing, K. McGoldrick/ Tuberculosis Drug Issues: Prices, Fixed Dose Combination Products and Second Line Drugs.
• 1999, August 10, 2001. Office of Rep. Elijah E. Cummings; Minority Staff Report for the House Committee on Government Reform and Oversight. Prescription Drug Pricing in the 7th Congressional District of Maryland: An International Price Comparison.
• 1999, August 2, Prescription Drug Pricing in the United States: Drug Companies Profit at the Expense of Older Americans, Minority Staff Report, Committee on Government Reform and Oversight, U.S. House of Representatives.
• 1999, November 9. Minority Staff, Special Investigations Division, Committee on Government Reform, U.S. House of Representatives. Prescription Drug Pricing in the United States: Drug Companies Profit at the Expense of older Americans.
• 1999, September. Health Insurance Association of America. Prescription Drugs: Cost and Coverage Trends.
• 1999. July 27. Alan Sager, Access and Affordability Monitoring Project, Boston University School of Public Health. Affordable Medications for Americans.
• 1998, July. The Congressional Budget Office. How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry.
• 1998, Summer. Larry D. Sasich, E. Fuller Torrey, and Sidney M. Wolfe. Public Citizen Health Research Group. Report on the International Comparison of Prices of Antidepressant and Antipsychotic Drugs.
• 1998 February 3. David Cantor for the Congressional Research Service. Prescription Drugs: Factors Influencing their Pricing.
• 1998, January 23. David Cantor for the Congressional Research Service. Prescription Drug Price Comparisons: The United States, Canada, and Mexico.
• Canada-Patented Medicine Prices Review Board (PMPRB)
• Canada's PMPRB-Study Series and Discussion Papers
• MSH International Drug Price Indicator Guide.